Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Aspira Women's Health Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 800 | 33 | −767 (−95.9%) |
| Value | $392 | $0 | −$392 (−100.0%) |
New holders (1)
Institutions that held Aspira Women's Health Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Motiv8 Investments LLC | 33 | $0 | 0.00% |
Sold out (1)
Institutions that held Aspira Women's Health Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Advisor Group Holdings, Inc. | 800 | $392 |